Find a company
Dissemination of the Newcastle MSI-PLUS assay for Lynch syndrome screening and therapeutic targeting.
| Project | Dissemination of the Newcastle MSI-PLUS assay for Lynch syndrome screening and therapeutic targeting |
|---|---|
| Description |
Dissemination of the Newcastle MSI-PLUS assay for Lynch syndrome screening and therapeutic targeting. |
| Funding | £ 1,720,326 |
| Competition | NHS Cancer Programme – Innovation Open Call 1 |
| Competition Date | February 2021 |
| Categories | Cancer |
| Website | https://www.newcastle-hospitals.nhs.uk/news/cancer-test-designed-by-newcastle-scientists-could-improve-survival-rates/ |